SCHEMBL6606468

SCHEMBL6606468

CCc1nc(C)c(-c2ccnc(Nc3ccc(S(=O)(=O)NCC4CC4)cc3)n2)[nH]1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 9/20 0.44
IKBKB O14920 5/20 0.43
CDK4 P11802 3/20 0.43
STK4 Q13043 2/20 0.43
CNR1 P21554 2/20 0.42
CNR2 P34972 2/20 0.42
CCNT1 O60563 2/20 0.40
CDK9 P50750 2/20 0.40
NPY5R Q15761 1/20 0.40
DKK1 O94907 1/20 0.40
GSK3B P49841 1/20 0.40
CDK1 P06493 1/20 0.40
CCNB1 P14635 1/20 0.40
CCNA2 P20248 1/20 0.40
CDK7 P50613 1/20 0.40
CCNH P51946 1/20 0.40
CCNA1 P78396 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6604316 0.87 CDK2 (0.50) CDK2CDK4CCNA2CCNA1
SCHEMBL6607780 0.87 CDK2 (0.41) CDK2IKBKBCDK4STK4CCNT1
SCHEMBL6604517 0.86 CDK2 (0.44) CDK2IKBKBCDK4STK4CNR1
SCHEMBL6603610 0.85 SYK (0.44) CDK2IKBKBCDK4CCNT1CDK9
SCHEMBL6606019 0.84 CDK2 (0.64) CDK2IKBKBCDK4CDK1
SCHEMBL5095478 0.76 CDK2 (0.56) CDK2CDK4STK4CCNT1CDK9
SCHEMBL6103961 0.76 CDK2 (0.72) CDK2CDK4CCNT1CDK9GSK3B
SCHEMBL6604567 0.76 CDK2 (0.64) CDK2IKBKBCDK4CDK1
SCHEMBL6606156 0.76 CDK2 (0.52) CDK2IKBKBCDK4CCNT1CDK9
SCHEMBL6104318 0.76 CDK2 (0.71) CDK2CDK4STK4CCNT1CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1490354-A1 4-IMIDAZOLYL SUBSTITUTED PYRIMIDINE DERIVATIVES WITH CDK INHIBITORY ACTIVITY Astrazeneca AB (SE) 2004-12-29 EP claimed
WO-2003076434-A1 4- IMIDAZOLYL SUBSTUITED PYRIMIDINE DERIVATIVES WITH CDK INHIBITIORY ACTIVITY ASTRAZENECA AB (SE) 2003-09-18 WO claimed
EP-1490354-A1 4-IMIDAZOLYL SUBSTITUTED PYRIMIDINE DERIVATIVES WITH CDK INHIBITORY ACTIVITY Astrazeneca AB (SE) 2004-12-29 EP disclosed
WO-2003076434-A1 4- IMIDAZOLYL SUBSTUITED PYRIMIDINE DERIVATIVES WITH CDK INHIBITIORY ACTIVITY ASTRAZENECA AB (SE) 2003-09-18 WO disclosed